Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Latest filing published 01 Oct 2026 for Maze Therapeutics, Inc., €69k.
Filing timeline
BuySaleAtul Dandekar
Insider track record
Disclosed buys
0
Disclosed sells
20
Signal history
Atul Dandekar: trading record in brief
All filings by Atul Dandekar on record concern Maze Therapeutics, Inc. We count 31 filings; the first trade dates from 29 December 2025 and the latest from 29 September 2026.
On the market, this insider has only sold: 20 sales, €4.3M in total. The rest of the record consists of 11 option exercises. In 2026 alone, the filings show no purchases and 17 sales.
The record was last updated on 1 October 2026 with an option exercise (€69k) in Maze Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Atul Dandekar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
7,500 shares@ US$10.42Common StockSEC:0002050167-26-000030:0
7,500 shares@ US$27.0561Common StockSEC:0002050167-26-000030:1
2,800 shares@ US$26.3760.0050% mcap3.4% of flowCommon StockSEC:0002050167-26-000027:0
391 shares@ US$27.12110.0007% mcap0.5% of flowCommon StockSEC:0002050167-26-000027:1
3,207 shares@ US$26.01330.0056% mcap3.8% of flowCommon StockSEC:0002050167-26-000027:2
36 shares@ US$25.810.0001% mcap0.0% of flowCommon StockSEC:0002050167-26-000027:3
12,500 shares0Common StockSEC:0002050167-26-000025:0
7,500 shares@ US$10.420.0052% mcap3.5% of flowCommon StockSEC:0002050167-26-000023:0
7,500 shares@ US$27.57650.014% mcap9.3% of flowCommon StockSEC:0002050167-26-000023:1
7,500 shares@ US$10.420.0054% mcap3.6% of flowCommon StockSEC:0002050167-26-000019:0
7,100 shares@ US$27.30640.013% mcap9.0% of flowCommon StockSEC:0002050167-26-000019:1
400 shares@ US$27.890.0008% mcap0.5% of flowCommon StockSEC:0002050167-26-000019:2
7,500 sharesCommon StockSEC:0002050167-26-000016:0
7,500 sharesCommon StockSEC:0002050167-26-000016:1
7,500 shares@ US$10.420.0043% mcap3.5% of flowCommon StockSEC:0002050167-26-000008:0
7,500 shares@ US$25.37320.010% mcap8.6% of flowCommon StockSEC:0002050167-26-000008:1
790 shares@ US$30.01731.1% of flowCommon StockSEC:0002050167-26-000006:2
7,500 shares@ US$10.423.6% of flowCommon StockSEC:0002050167-26-000006:0
6,710 shares@ US$29.25569.0% of flowCommon StockSEC:0002050167-26-000006:1
7,500 shares@ US$10.423.5% of flowCommon StockSEC:0002050167-26-000005:0
7,500 shares@ US$10.423.4% of flowCommon StockSEC:0002050167-26-000003:0
72,400 shares@ US$10.4233.7% of flowCommon StockSEC:0002050167-25-000007:0
22 of 22 declarations
